From: The neurobiology of suicide - A Review of post-mortem studies
Gene symbol | Description | Change | Location | Diagnosis | Reference |
---|---|---|---|---|---|
A2M | alpha-2-macroglobulin | upregulation | PFC | SCH | 35 |
ABCG2 | ATP-binding cassette, sub-family G(WHITE), member 2 | upregulation | PFC | aSCH | 35 |
ADCY8 | adenylate cyclase 8 (brain) | upregulation | LS | MD | 27 |
ADRA2A | adrenoceptor alpha 2A | higher frequency of the C1291G SNP | G | upregulated | 73, 115 |
ADRA2B | adrenoceptor alpha 2B | higher frequency of the rs1018351 SNP | G | NC | 116 |
AGT | angiotensinogen (serpin peptidase inhibitor, clade A, member 8) | downregulation | PFC | SCH | 35 |
AGXT2L1 | alanine-glyoxylate aminotransferase 2-like 1 | downregulation | PFC | SCH | 35 |
AHCYL1 | S-adenosylhomocysteine hydrolase-like 1 | downregulation | PFC | SCH | 35 |
ALDH1L1 | aldehyde dehydrogenase 1 family, member L1 | downregulation | PFC | SCH | 35 |
APLP2 | amyloid beta (A4) precursor-like protein 2 | upregulation | L | MD | 27 |
APOE | Apolipoprotein E | downregulation | PFC | SCH | 35 |
APOLD1 | apolipoprotein L domain containing 1 | downregulation | PFC | SCH | 35 |
ATP1A2 | ATPase, Na+/K+ transporting, alpha 2 (+) polypeptide | downregulation | PFC | SCH | 35 |
ATP1B2A | ATPase, Na+/K+ transporting, beta 2 polypeptide | downregulation | PFC | SCH | 35 |
BACE1 | beta-site APP-cleaving enzyme 1 | upregulation | LS | MD | 27 |
BBOX1 | butyrobetaine (gamma), 2-oxoglutarate dioxygenase 1 | downregulation | PFC | SCH | 35 |
BDNF | brain-derived neurotrophic factor | downregulatoin | PFC, | HIP NC | 173, 174 |
C3 | complement component 3 | upregulation | PFC | SCH | 35 |
CD74 | CD74 molecule, major histocompatibility complex, class II invariant chain | upregulation | PFC | SCH | 35 |
CDCA7L | cell division cycle associated 7-like | not characterised | PFC | NC | 34 |
CDH12 | cadherin 12, type 2 (N-cadherin 2) | not characterised | PFC | NC | 34 |
CHI3L1 | chitinase 3-like 1 (cartilage glycoprotein-39) | downregulation | PFC | BD | 35 |
CLDN10 | claudin 10 | downregulation | PFC | SCH | 35 |
COMT | catechol-O-methyltransferase | higher frequency of the val158met SNP | G | NC, male suicides only | 125 |
CRH | corticotropin releasing hormone | upregulation | PFC | SCH | 35 |
CSF1R | colony stimulating factor 1 receptor | upregulation | PFCS | CH | 35 |
CX3CR1 | chemokine (C-X3-C motif) receptor 1 | upregulation | PFC | SCH | 35 |
DARPP-32 | protein phosphatase 1, regulatory (inhibitor) subunit 1B | downregulation | PFC | SCH | 128 |
DDIT4 | DNA-damage-inducible transcript 4 | downregulation | PFC | SCH | 35 |
DUSP6 | dual specificity phosphatase 6 | upregulation | PFC | SCH | 35 |
EFEMP1 | EGF-containing fibulin-like extracellular matrix protein 1 | downregulation | PFC | SCH | 35 |
EFEMP1 | EGF containing fibulin-like extracellular matrix protein 1 | not characterised | PFC | NC | 34 |
EIF5A | eukaryotic translation initiation factor 5A | downregulation | PFC | SCH | 35 |
EMX2 | empty spiracles homolog 2 (Drosophila) | downregulation | PFC | SCH | 34, 35 |
EMX2 | empty spiracles homolog 2 (Drosophila) | downregulation | PFC | BD | 35 |
EPHX1 | epoxide hydrolase 1, microsomal (xenobiotic) | downregulation | PFC | SCH | 35 |
EVC | Ellis van Creveld syndrome | higher frequency of the rs1383180 polymorhism | G | NC, male suicides only | 26 |
FAM107A | family with sequence similarity 107, member A | downregulation | PFC | SCH | 35 |
FGFR3 | fibroblast growth factor receptor 3 (achondroplasia, thanatophoric dwarfism) | downregulation | PFC | SCH | 35 |
FXYD1 | FXYD domain containing ion transport regulator 1 (phospholemman) | downregulation | PFC | SCH | 35 |
GABRA1 | gamma-aminobutyric acid (GABA) A receptor, alpha 1 | upregulation | LS | MD | 27 |
GABRA5 | gamma-aminobutyric acid (GABA) A receptor, alpha 5 | upregulation | PFC | BD | 34, 35 |
GABRB1 | gamma-aminobutyric acid (GABA) A receptor, beta 1 | upregulation | LS | MD | 27 |
GLUL | glutamate-ammonia ligase (glutamine synthetase) | downregulation | PFC | SCH | 35 |
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | upregulation | PFC | SCH | 35 |
HLA-DRA | major histocompatibility complex, class II, DR alpha | upregulation | PFC | SCH | 35 |
HSPB1 | heat shock 27 kDa protein 1 | downregulation | PFC | SCH | 35 |
HTR2C | 5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled | higher frequency of the Cys23Ser polymorhism | G | NC, female suicides only | 84 |
ID4 | inhibitor of DNA binding 4, dominant negative helix-loop-helix protein | downregulation | PFC | SCH | 36 |
IL17RB | interleukin 17 receptor B | downregulation | PFC | SCH | 35 |
ITGB4 | integrin, beta 4 | downregulation | PFC | SCH | 35 |
ITPKB | inositol 1,4,5-trisphosphate 3-kinase B | downregulation | PFC | SCH | 35 |
LAPTM5 | lysosomal associated multispanning membrane protein 5 | upregulation | PFC | SCH | 35 |
LDLR | low density lipoprotein receptor | downregulation | PFC | BD | 35 |
LOC645745 | metallothionein 1H-like protein | downregulation | PFC | SCH | 35 |
lTrkB | neurotrophic tyrosine kinase, receptor, type 2 | downregulation | PFC, | HIP NC | 171 |
METTL7A | methyltransferase like 7A | downregulation | PFC | SCH | 35 |
MLC1 | megalencephalic leukoencephalopathy with subcortical cysts 1 | downregulation | PFC | SCH | 35 |
MLC1 | megalencephalic leukoencephalopathy with subcortical cysts 1 | not characterised | PFC | NC | 34 |
MT1E | metallothionein 1E (functional) | downregulation | PFC | SCH | 35 |
MT1F | metallothionein 1F (functional) | downregulation | PFC | SCH | 35 |
MT1G | metallothionein 1G | dcownregulation | PFC | SCH | 35 |
MT1H | metallothionein 1H | downregulation | PFC | SCH | 35 |
MT1M | metallothionein 1M | downregulation | PFC | SCH | 35 |
MT1X | metallothionein 1X | downregulation | PFC | SCH | 35 |
NAV2 | neuron navigator | downregulation | PFC | BD | 35 |
NDRG2 | NDRG family member 2 | downregulation | PFC | SCH | 35 |
NOTCH2 | Notch homolog 2 (Drosophila) | downregulation | PFC | SCH | 35 |
NPY | neuropeptide Y | upregulation | PFC | SCH | 35 |
NTRK2 | neurotrophic tyrosine kinase, receptor, type 2 | downregulation | PFC | SCH | 35 |
NTSR2 | neurotensin receptor 2 | downregulation | PFC | SCH | 35 |
P2RY13 | purinergic receptor P2Y, Gprotein coupled, 13 | upregulation | PFC | SCH | 35 |
p75NTR (NGFR) | nerve growth factor receptor | higher frequency of the missense polymorphism (S205L) | G | MD | 23 |
PCDHB5 | protocadherin beta 5 | NC | PFC | NC | 34 |
PLSCR4 | phospholipid scramblase 4 | downregulation | PFC | SCH | 34, 35 |
PLSCR4 | phospholipid scramblase 4 | downregulation | PFC | BD | 35 |
PPAP2B | phosphatidic acid phosphatase type 2B | downregulation | PFC | SCH | 35 |
PRKCI | protein kinase C, iota | upregulated | PFC | NC | 150 |
PTPRR | protein tyrosine phosphatase, receptor type, R | downregulation | PFC | NC | 34 |
RAB31 | RAB31, member RAS oncogene family | downregulation | PFC | SCH | 35 |
RHOBTB34 | Rho-related BTB domain containing 3 | downregulation | PFC | SCH | 35 |
S100A13 | S100 calcium binding protein A13 | not characterised | PFC | NC | 34 |
SAT1 | spermidine/spermine N1-acetyltransferase 1 | downregulation, higher frequency of the rs6526342 SNP | PFC | MD | 186, 187, 188, 189, 190, 192 |
SCN2B | sodium channel, voltage-gated, type II, beta subunit | not characterised | PFC | NC | 34 |
SDC2 | syndecan 2 (heparan sulfate proteoglycan 1, cell surfaceassociated, fibroglycan) | downregulation | PFC | SCH | 35 |
SDC4 | syndecan 4 (amphiglycan, ryudocan) | downregulation | PFC | SCH | 35 |
SLC14A1 | solute carrier family 14 (urea transporter), member 1 (Kidd blood group) | downregulation | PFC | SCH | 35 |
SLC1A3 | solute carrier family 1 (glial high affinity glutamate transporter), member 3 | downregulation | PFC | SCH | 35 |
SLC25A23 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 23 | upregulation | PFC | SCH | 35 |
SLC4A4 | solute carrier family 4, sodium bicarbonate cotransporter, member 4 | downregulation | PFC | SCH | 35 |
SLC6A3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | higher frequency of the rs403636 SNP | G | NC | 116 |
SLC7A11 | solute carrier family 7, (cationic amino acid transporter, y+system) member 11 | downregulation | PFC | SCH | 35 |
SOX9 SRY | (sex determining region Y)-box 9 | downregulation | PFC | SCH | 35 |
SPON1 | spondin 1, extracellular matrix protein | downregulation | PFC | SCH | 35 |
STCH | stress 70 protein chaperone, microsome-associated, 60 kDa | upregulation | PFC | BD | 35 |
SYT4 | synaptotagmin IV upregulation LS MD 27 TIMP1 TIMP metallopeptidase inhibitor 1 | downregulation | PFC | BD | 35 |
TM4SF1 | transmembrane 4 L six family member 1 | downregulation | PFC | BD | 35 |
TNFSF10 | tumor necrosis factor (ligand) superfamily, member 10 | upregulation | PFC | SCH | 35 |
TP53BP2 | tumor protein p53 binding protein, 2 | downregulation | PFC | SCH | 35 |
TPD52L1 | tumor protein D52-like 1 | downregulation | PFC | SCH | 35 |
TPH2 | tryptophan hydroxylase 2 | higher frequeny of the rs1386494 SNP | G | NC | 88 |
TRIM23 | tripartite motif-containing 23 | upregulation | PFC | BD | 35 |
TUBB2B | tubulin, beta 2B | downregulation | PFC | SCH | 35 |
TYROBP | TYRO protein tyrosine kinase binding protein | upregulation | PFC | SCH | 35 |
VIL2 | villin 2 (ezrin) | downregulation | PFCS | CH | 35 |
WFS1 | Wolfram syndrome 1 (wolframin) | higher frequency of the 611R/611R genotype | G | NC | 21, 22 |
ZFP36 | ZFP36 ring finger protein | not characterised | PFC | NC | 34 |
ZHX2 | zinc fingers and homeoboxes 2 | downregulation | PFC | BD | 35 |
ZIC1 | Zic family member 1 (odd-paired homolog, Drosophila) | downregulation | PFC | BD | 35 |